Schonfeld Strategic Advisors LLC Pa Vmed Inc. Transaction History

Schonfeld Strategic Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.85 - $1.41 $9,265 - $15,369	-10,900 Reduced 10.37%	94,200 $88,000
Q1 2022 May 16, 2022	BUY	$1.16 - $2.5 $121,915 - $262,750	105,100 New	105,100 $139,000
Q2 2021 Aug 16, 2021	SELL	$3.95 - $6.88 $217,645 - $379,088	-55,100 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$2.01 - $5.55 $79,394 - $219,225	39,500 Added 253.21%	55,100 $245,000
Q4 2020 Feb 16, 2021	BUY	$1.73 - $2.13 $26,988 - $33,228	15,600 New	15,600 $33,000

2.24M

Ticker PAVM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 90,999,104
Market Cap $64.6M
Description
PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE); and EsoGuard, a bisulfite-converted ne...

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.